INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | – | 50 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 50 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 50 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 50 | -99.1% | 0.00% | – |
| Q2 2016 | $70,000 | -18.6% | 5,400 | 0.0% | 0.00% | – |
| Q1 2016 | $86,000 | -93.7% | 5,400 | -88.7% | 0.00% | -100.0% |
| Q4 2015 | $1,367,000 | +1.3% | 47,705 | +0.6% | 0.01% | 0.0% |
| Q3 2015 | $1,349,000 | -36.9% | 47,405 | -20.4% | 0.01% | -27.3% |
| Q2 2015 | $2,138,000 | +23.7% | 59,520 | +100.0% | 0.01% | +22.2% |
| Q1 2015 | $1,729,000 | +70.2% | 29,760 | +23.5% | 0.01% | +80.0% |
| Q4 2014 | $1,016,000 | – | 24,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
| Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
| Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
| SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
| Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
| JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
| TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
| GAM Holding AG | 83,940 | $745,000 | 0.03% |
| Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |